#9,122 by institutional money · Stock
BriaCell Therapeutics Corp. (BCTXL)
Institutional ownership from Q3 2026 Form 13F filings
$0.82
−9.16% today
Market closed. Prices as of Nov 20, 8:11 AM ET
- 13F holders
- 11 (+1)
- Held by 13F filers, live
- $2.4M
- Shares held
- 2,879,818
- Share of stock outstanding
- n/a
- Net buying in Q3 2026
- −$62K
- New positions / sold out
- 1 / 0
Largest holders
11 investors| Investor | Shares | Value, live | % of their portfolio | vs Q2 2026 |
|---|---|---|---|---|
| Citadel Advisors LLC Ken Griffin | 850,897 | $698K | <0.1% | Reduced −5% |
| Armistice Capital, LLC | 536,600 | $440K | <0.1% | Unchanged |
| Cable Car Capital, LP | 321,898 | $264K | 0.11% | Unchanged |
| Empery Asset Management, LP | 300,000 | $246K | 0.37% | Unchanged |
| MYDA Advisors LLC | 195,000 | $160K | <0.1% | Reduced −0% |
| Heights Capital Management, Inc | 186,582 | $153K | <0.1% | Unchanged |
| Warberg Asset Management LLC | 181,612 | $149K | 0.14% | Added +14% |
| Sabby Management, LLC | 136,365 | $112K | 1.95% | Reduced −28% |
| Clear Street Group Inc. | 104,196 | $85K | <0.1% | Unchanged |
| Iridian Asset Management LLC/ct | 65,000 | $53K | <0.1% | Unchanged |
| UBS Group AG | 1,668 | $1K | <0.1% | New |